Literature DB >> 10085028

Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.

M Varughese1, A V Teixeira, S Liu, S H Leppla.   

Abstract

Anthrax toxin from Bacillus anthracis is a three-component toxin consisting of lethal factor (LF), edema factor (EF), and protective antigen (PA). LF and EF are the catalytic components of the toxin, whereas PA is the receptor-binding component. To identify residues of PA that are involved in interaction with the cellular receptor, two solvent-exposed loops of domain 4 of PA (amino acids [aa] 679 to 693 and 704 to 723) were mutagenized, and the altered proteins purified and tested for toxicity in the presence of LF. In addition to the intended substitutions, novel mutations were introduced by errors that occurred during PCR. Substitutions within the large loop (aa 704 to 723) had no effect on PA activity. A mutated protein, LST-35, with three substitutions in the small loop (aa 679 to 693), bound weakly to the receptor and was nontoxic. A mutated protein, LST-8, with changes in three separate regions did not bind to receptor and was nontoxic. Toxicity was greatly decreased by truncation of the C-terminal 3 to 5 aa, but not by their substitution with nonnative residues or the extension of the terminus with nonnative sequences. Comparison of the 28 mutant proteins described here showed that the large loop (aa 704 to 722) is not involved in receptor binding, whereas residues in and near the small loop (aa 679 to 693) play an important role in receptor interaction. Other regions of domain 4, in particular residues at the extreme C terminus, appear to play a role in stabilizing a conformation needed for receptor-binding activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085028      PMCID: PMC96538          DOI: 10.1128/IAI.67.4.1860-1865.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Entry of diphtheria toxin-protein A chimeras into cells.

Authors:  I H Madshus; H Stenmark; K Sandvig; S Olsnes
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis.

Authors:  C P Quinn; Y Singh; K R Klimpel; S H Leppla
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

4.  Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity.

Authors:  K R Klimpel; N Arora; S H Leppla
Journal:  Mol Microbiol       Date:  1994-09       Impact factor: 3.501

5.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells.

Authors:  V Escuyer; R J Collier
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin.

Authors:  V M Gordon; S H Leppla; E L Hewlett
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

8.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

Authors:  A M Friedlander
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

9.  A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.

Authors:  C P Theuer; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.486

10.  A recombinant diphtheria toxin related human CD4 fusion protein specifically kills HIV infected cells which express gp120 but selects fusion toxin resistant cells which carry HIV.

Authors:  P Aullo; J Alcami; M R Popoff; D R Klatzmann; J R Murphy; P Boquet
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  33 in total

1.  Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib.

Authors:  J C Marvaud; T Smith; M L Hale; M R Popoff; L A Smith; B G Stiles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding.

Authors:  D Blöcker; H Barth; E Maier; R Benz; J T Barbieri; K Aktories
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

4.  Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

Authors:  D Borden Lacy; Darran J Wigelsworth; Roman A Melnyk; Stephen C Harrison; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

5.  Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Authors:  E D Williamson; I Hodgson; N J Walker; A W Topping; M G Duchars; J M Mott; J Estep; C Lebutt; H C Flick-Smith; H E Jones; H Li; C P Quinn
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.

Authors:  Kuang-Hua Chen; Shihui Liu; Laurie A Bankston; Robert C Liddington; Stephen H Leppla
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

7.  A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Authors:  Andrei P Pomerantsev; Olga M Pomerantseva; Mahtab Moayeri; Rasem Fattah; Cynthia Tallant; Stephen H Leppla
Journal:  Protein Expr Purif       Date:  2011-08-07       Impact factor: 1.650

8.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

Review 9.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

10.  Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Authors:  Johnny W Peterson; Jason E Comer; Wallace B Baze; David M Noffsinger; Autumn Wenglikowski; Kristin G Walberg; Jason Hardcastle; Jennifer Pawlik; Kathryn Bush; Joanna Taormina; Scott Moen; John Thomas; Bagram M Chatuev; Laurie Sower; Ashok K Chopra; Lawrence R Stanberry; Ritsuko Sawada; Wolfgang W Scholz; Jagadish Sircar
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.